Potential role of irisin in lung diseases and advances in research.

biomarker diagnostic irisin lung disease treatment

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2023
Historique:
received: 05 10 2023
accepted: 27 11 2023
medline: 25 12 2023
pubmed: 25 12 2023
entrez: 25 12 2023
Statut: epublish

Résumé

Irisin, a myokine, is secreted by the movement of skeletal muscles. It plays an important role in metabolic homeostasis, insulin resistance, anti-inflammation, oxidative stress, and bone metabolism. Several studies have reported that irisin-related signaling pathways play a critical role in the treatment of various diseases, including obesity, cardiovascular disease, diabetes, and neurodegenerative disorders. Recently, the potential role of irisin in lung diseases, including chronic obstructive pulmonary disease, acute lung injury, lung cancer, and their associated complications, has received increasing attention. This article aims to explore the role of irisin in lung diseases, primarily focusing on the underlying molecular mechanisms, which may serve as a marker for the diagnosis as well as a potential target for the treatment of lung diseases, thus providing new strategies for their treatment.

Identifiants

pubmed: 38143500
doi: 10.3389/fphar.2023.1307651
pii: 1307651
pmc: PMC10746167
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1307651

Informations de copyright

Copyright © 2023 Dong, Lv, Gao and Hao.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Hongna Dong (H)

Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, Jilin, China.

Xuejiao Lv (X)

Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, Jilin, China.

Peng Gao (P)

Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, Jilin, China.

Yuqiu Hao (Y)

Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, Jilin, China.

Classifications MeSH